A

Amerisourcebergen Corp
LSE:0HF3

Watchlist Manager
Amerisourcebergen Corp
LSE:0HF3
Watchlist
Price: 310.53 USD 2.08%
Market Cap: $64.4B

EV/S

0.2
Current
20%
More Expensive
vs 3-y average of 0.2

Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.

EV/S
0.2
=
Enterprise Value
$76.8B
/
Revenue
$325.8B

Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.

EV/S
0.2
=
Enterprise Value
$76.8B
/
Revenue
$325.8B

Valuation Scenarios

Amerisourcebergen Corp is trading above its 3-year average

If EV/S returns to its 3-Year Average (0.2), the stock would be worth $258.41 (17% downside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-25%
Maximum Upside
+1 398%
Average Upside
569%
Scenario EV/S Value Implied Price Upside/Downside
Current Multiple 0.2 $310.53
0%
3-Year Average 0.2 $258.41
-17%
5-Year Average 0.2 $233.98
-25%
Industry Average 2.1 $3 165.33
+919%
Country Average 3 $4 651.62
+1 398%

Forward EV/S
Today’s price vs future revenue

Today's Enterprise Value Revenue Forward EV/S
$76.8B
/
Jan 2026
$325.8B
=
0.2
Current
$76.8B
/
Sep 2026
$349.9B
=
0.2
Forward
$76.8B
/
Sep 2027
$373.5B
=
0.2
Forward
$76.8B
/
Sep 2028
$400B
=
0.2
Forward
$76.8B
/
Sep 2029
$426.5B
=
0.2
Forward
$76.8B
/
Sep 2030
$454.9B
=
0.2
Forward

Forward EV/S shows whether today’s EV/S still looks high or low once future revenue are taken into account.

Peer Comparison

All Multiples
EV/S
P/E
All Countries
Close

Market Distribution

Lower than 98% of companies in the United States of America
Percentile
2st
Based on 11 256 companies
2st percentile
0.2
Low
0 — 1.6
Typical Range
1.6 — 5.3
High
5.3 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 1.6
Median 3
70th Percentile 5.3
Max 4 613 320.1

Amerisourcebergen Corp
Glance View

AmerisourceBergen Corp., a titan in the realm of pharmaceutical services, orchestrates the flow of medications across a vast and intricate network. Rooted in Chesterbrook, Pennsylvania, the company has cemented its place as a critical link in the healthcare supply chain. Serving as a bridge between pharmaceutical manufacturers and a wide array of healthcare providers like hospitals, clinics, and pharmacies, AmerisourceBergen leverages its expansive distribution infrastructure to ensure that medications and health products reach their destinations efficiently and reliably. The company's operations are bolstered by its strategic partnerships and collaboration with a plethora of healthcare entities, enabling it to integrate seamlessly into the delivery systems that support patient care. At its core, AmerisourceBergen turns the complexity of healthcare logistics into a streamlined process, generating revenue primarily through the distribution of pharmaceuticals. It purchases medications from manufacturers, sells them at a markup to healthcare providers, and in doing so, balances a robust supply chain fueled by efficiency and scale. But the story doesn't end at distribution; the company has expanded its reach through value-added services such as consulting, data analytics, and patient support services that further solidify its role in the healthcare ecosystem. Whether navigating regulatory environments or advising on patient care strategies, AmerisourceBergen positions itself as not just a distributor, but a partner in health. Through this dual approach of distribution and strategic services, the company ensures it remains vital to both manufacturers and healthcare providers, creating a sustainable business model that capitalizes on both volume and innovation.

0HF3 Intrinsic Value
502.14 USD
Undervaluation 38%
Intrinsic Value
Price $310.53
A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett